Compare WAT & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAT | CIB |
|---|---|---|
| Founded | 1958 | 1945 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Commercial Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 14.5B |
| IPO Year | 1995 | 1995 |
| Metric | WAT | CIB |
|---|---|---|
| Price | $386.32 | $75.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 5 |
| Target Price | ★ $390.67 | $56.25 |
| AVG Volume (30 Days) | ★ 482.7K | 342.5K |
| Earning Date | 02-11-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 5.50% |
| EPS Growth | 3.82 | ★ 22.14 |
| EPS | ★ 10.88 | 1.96 |
| Revenue | $3,105,638,000.00 | ★ $6,289,868,892.00 |
| Revenue This Year | $7.93 | $33.27 |
| Revenue Next Year | $6.30 | $7.26 |
| P/E Ratio | $36.28 | ★ $10.23 |
| Revenue Growth | 6.90 | ★ 15.25 |
| 52 Week Low | $275.05 | $31.78 |
| 52 Week High | $423.56 | $74.79 |
| Indicator | WAT | CIB |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 83.50 |
| Support Level | $383.07 | $66.41 |
| Resistance Level | $401.74 | $68.60 |
| Average True Range (ATR) | 9.25 | 1.77 |
| MACD | -0.39 | 0.83 |
| Stochastic Oscillator | 35.81 | 94.55 |
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.